108
Participants
Start Date
September 30, 2008
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
oxycodone IR
maximum daily dose 450 mg
placebo
5 or 10 mg capsule every 4 - 6 hr as needed for up to 10 days
tapentadol IR
50 or 75 mg capsule every 4 - 6 hr as needed for up to 10 days
Haleyville
Tallassee
Peoria
Tucson
Encinitas
Los Gatos
Mission Viejo
Oakland
Roseville
San Diego
Studio City
Vista
Bradenton
Hialeah
Kissimmee
Miami Springs
Ormond Beach
Saint Cloud
Vero Beach
Atlanta
Gainesville
Peachtree
Savannah
Valdosta
Bloomington
South Bend
Covington
Minneapolis
North Massapequa
Hickory
Akron
Canton
Marion
Eugene
Aiken
Houston
Mesquite
Collaborators (1)
Grünenthal GmbH
INDUSTRY
Ortho-McNeil Janssen Scientific Affairs, LLC
INDUSTRY